Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020

Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023

Published:2024-06-07 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Parker Casey E.¹²,Hause Anne M.¹,Marquez Paige¹,Zhang Bicheng¹,Myers Tanya R.¹,Shay David K.¹

Affiliation:

1. Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA

2. ORISE Health Studies Program, Oak Ridge Associated Universities, Oak Ridge, TN, USA

Funder

author(s) reported that there is no funding associated with

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2361946

Reference20 articles.

1. Mbaeyi S. Use of Pfizer-BioNTech COVID-19 Vaccine: clinical Considerations. ACIP COVID-19 Vaccines Work Group. December 19, 2020. Atlanta, GA: The Advisory Committee on Immunization Practices Meeting.

2. Meeting of the Advisory Committee on Immunization Practices (ACIP), MAY 12, 2021;Advisory Committee on Immunization Practices;Meeting Minutes

3. The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021

4. Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022

5. The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC’s COVID-19 pandemic response